医薬品の安全性評価における組織分布試験の意義

The 41th Annual Meeting of the Japanese Society of Toxicology

Session ID : W3-2

Conference information

Host: The Japanese Society of Toxicology

Workshop 3

The significance of tissues distribution study for drug safety evaluation

Author information

*Toshiya MINAGAWA
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association
Eri KANEOKA
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association
Kenji SHINKAI
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association
Nariaki YAGI
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association
Kenzo YAMAMURA
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association
Ryoichi KURAHASHI
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association
Shin-ichi MIURA
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association
Kazuichi NAKAMURA
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association

CONFERENCE PROCEEDINGS FREE ACCESS

Details